Evaluation of the inhibitory effect of abamectin on mammalian butyrylcholinesterase: Enzyme kinetic and molecular docking studies

References

• Lasota, J. A.; Dybas, R. A. Avermectins, a novel class of compounds: implications for use in arthropod pest control. Ann. Rev. Entomol. 1991, 36(1), 91–117. DOI: 10.1146/annurev.en.36.010191.000515.
   PubMedGoogle Scholar
• Campbell, W. C. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents. Curr. Pharm. Biotechnol. 2012, 13(6), 853–865. DOI: 10.2174/138920112800399095.
   PubMed Web of Science ®Google Scholar
• Solecki, R.; Niemann, L. Insecticides of natural origin, other than pyrethrum and nicotine. In Mammalian Toxicology of Insecticides, Marrs, T. C., Ed.; Royal Society of Chemistry: Cambridge, UK, 2012; pp 254–287.
   Google Scholar
• Reddy, P. P. Avermectins. In Recent Advances in Crop Protection, Reddy, P. P., Ed.; Springer: Berlin, Germany, 2013; pp 13–24.
   Google Scholar
• ffrench-Constant, R. H.; Williamson, M. S.; Emyr Davies, T. G.; Bass, C. Ion channels as insecticide targets. J. Neurogenet. 2016, 30(3–4), 163–177. DOI: 10.1080/01677063.2016.1229781.
   PubMed Web of Science ®Google Scholar
• Woodward, K. N. Macrocyclic lactone endectocides. In Mammalian Toxicology of Insecticides, Marrs, T. C., Ed.; Royal Society of Chemistry: Cambridge, UK, 2012; pp 427–467.
   Google Scholar
• Geula, C.; Darvesh, S. Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease. Drugs Today (Barc.). 2004, 40(8), 711–721. DOI: 10.1358/dot.2004.40.8.850473.
   PubMed Web of Science ®Google Scholar
• Reid, G. A.; Chilukuri, N.; Darvesh, S. Butyrylcholinesterase and the cholinergic system. Neuroscience. 2013, 234, 53–68. DOI: 10.1016/j.neuroscience.2012.12.054.
   PubMed Web of Science ®Google Scholar
• Nordberg, A.; Ballard, C.; Bullock, C.; Darreh-Shori, T.; Somogyi, M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. Prim. Care Companion CNS Disord. 2013, 15(2), PCC.12r01412. DOI: 10.4088/PCC.12r01412.
   PubMedGoogle Scholar
• Ellman, G. L.; Courtney, K. D.; Anders, V.; Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7(2), 88–95. DOI: 10.1016/0006-2952(61)90145-9.
   PubMed Web of Science ®Google Scholar
• Nielsen, M.; Lundegaard, C.; Lund, O.; Petersen, T. N. CPHmodels-3.0—remote homology modeling using structure-guided sequence profiles. Nucleic Acids Res. 2010, 38(Web Server issue), W576–W581. DOI: 10.1093/nar/gkq535.
   PubMedGoogle Scholar
• Schwab, C. H. Conformations and 3D pharmacophore searching. Drug Discov. Today Technol. 2010, 7(4), e245–e253. DOI: 10.1016/j.ddtec.2010.10.003.
   Google Scholar
• Schneidman-Duhovny, D.; Inbar, Y.; Nussinov, R.; Wolfson, H. J. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 2005, 33(Web Server issue), W363–W367. DOI: 10.1093/nar/gki481.
   PubMed Web of Science ®Google Scholar
• Salentin, S.; Schreiber, S.; Haupt, V. J.; Adasme, M. F.; Schroeder, M. PLIP: fully automated protein–ligand interaction profiler. Nucleic Acids Res. 2015, 43(W1), W443–W447. DOI: 10.1093/nar/gkv315.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23(1–3), 3–25. DOI: 10.1016/S0169-409X(96)00423-1.
   Web of Science ®Google Scholar
• Driggers, E. M.; Hale, S. P.; Lee, J.; Terrett, N. K. The exploration of macrocycles for drug discovery — an underexploited structural class. Nat. Rev. Drug Discov. 2008, 7(7), 608–624. DOI: 10.1038/nrd2590.
   PubMed Web of Science ®Google Scholar
• Kumar, A.; Singh, A.; Ekavali. A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol. Rep. 2015, 67(2), 195–203. DOI: 10.1016/j.pharep.2014.09.004.
   PubMed Web of Science ®Google Scholar
• Inestrosa, N. C.; Alvarez, A.; Pérez, C. A.; Moreno, R. D.; Vicente, M.; Linker, C.; Casanueva, O. I.; Soto, C.; Garrido, J. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron. 1996, 16(4), 881–891. DOI: 10.1016/S0896-6273(00)80108-7.
   PubMed Web of Science ®Google Scholar
• Guillozet, A. L.; Smiley, J. F.; Mash, D. C.; Mesulam, M. M. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 1997, 42(6), 909–918. DOI: 10.1002/ana.410420613.
   PubMed Web of Science ®Google Scholar
• Reyes, A. E.; Perez, D. R.; Alvarez, A.; Garrido, J.; Gentry, M. K.; Doctor, B. P.; Inestrosa, N. C. Biochem. Biophys. Res. Commun. 1997, 232(3), 652–655. DOI: 10.1006/bbrc.1997.6357.
   PubMedGoogle Scholar
• Bartolini, M.; Bertucci, C.; Cavrini, V.; Andrisano, V. β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem. Pharmacol. 2003, 65(3), 407–416. DOI: 10.1016/S0006-2952(02)01514-9.
   PubMed Web of Science ®Google Scholar